Pan-cancer analysis indicated that G6PC1 was significantly downregulated in most cancer types, such as liver cancer, bile duct cancer, colon cancer, kidney clear cell carcinoma, kidney papillary cell carcinoma, and kidney chromophobe (Figure 1A). Here, G6PC1 is linked to cancer.